Product: Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Reason for recall: Cross Contamination with Other Products
Recall initiated: 20240409
Status: Ongoing
Classification: Class III
Recall type: Voluntary: Firm initiated